Psoriatic Arthritis

Resource Center

FDA Alerts

Treatment

Treatment

FDA Approves First Treatment for Active Psoriatic Arthritis in Pediatric Patients

08/23/2022

Medication prescribing

FDA Approves New Treatment Option for Patients With Psoriatic Arthritis

01/24/2022

The US Food and Drug Administration has approved the drug based on the results from the KEEPsAKE-1 and KEEPsAKE-2 randomized, placebo-controlled studies.

01/24/2022

Research Summaries

research summary

research summary

Secukinumab Improves Disease Severity, Functional Outcomes for Psoriatic Arthritis

05/16/2023

Leigh Precopio

To better understand the potential benefits of secukinumab use in patients with psoriatic arthritis, researchers examined the proportion of patients being treated with secukinumab that achieved low disease...

05/16/2023

Research Summary

Treatment of Psoriatic Arthritis in Pregnant Women Increases Risks

04/28/2023

Jessica Ganga

The researchers evaluated the impact of antirheumatic treatment in women who are pregnant with psoriatic arthritis and how such treatment affects pregnancy outcomes.

04/28/2023

Research Summary

Cannabidiol Equal to Placebo in Pain Reduction For Patients With Psoriatic Arthritis

04/13/2023

Jessica Ganga

Researchers conducted a trial to investigate the use of cannabidiol (CBD) to help manage pain in patients with psoriatic arthritis and hand osteoarthritis.

04/13/2023

research summary

research summary

Ultrasound Is Effective as Subclinical PsA Screening Tool

03/21/2023

treatment

Better Clinical Responses Observed With Early Initiation of DMARD Therapy in Treatment of PsA

11/28/2022

May 2023

Current Issue

May 2023

Volume 63

Issue 5